سعر بيرجاتون 20مجم 30 قرص 2025

Stimulant laxative tablets containing calcium sennosides 20 mg, 30 tablets (3 strips) (Memphis, Egypt).

• Intestinal obstruction or stenosis, atony, appendicitis, inflammatory bowel disease (e.g. Crohn disease, ulcerative colitis), abdominal pain of unknown origin, severe dehydration with water and electrolyte depletion; children under 12 years; pregnancy and lactation; hypersensitivity.General active-ingredient information · European Medicines Agency (EMA), HMPC

• Long-term use of stimulant laxatives should be avoided (risk of impaired bowel function and laxative dependence); if laxatives are needed daily, investigate the cause. Not to be used for more than 1 week without medical advice.General active-ingredient information · European Medicines Agency (EMA), HMPC
• Patients taking cardiac glycosides, antiarrhythmics, QT-prolonging drugs, diuretics, corticosteroids or liquorice root should consult a doctor; patients with kidney disorders should be aware of possible electrolyte imbalance.General active-ingredient information · European Medicines Agency (EMA), HMPC

• Cardiac glycosides / antiarrhythmicsHypokalaemia from long-term laxative abuse potentiates cardiac glycosides and interacts with antiarrhythmic medicinal products.European Medicines Agency (EMA), HMPC
• Diuretics, corticosteroids, liquorice rootConcomitant use may enhance potassium loss.European Medicines Agency (EMA), HMPC

• Use during pregnancy is contraindicated (experimental data on genotoxic risk of several anthranoids, e.g. emodin and aloe-emodin).General active-ingredient information · European Medicines Agency (EMA), HMPC
• Use during lactation is contraindicated: active metabolites such as rhein are excreted in breast milk in small amounts.General active-ingredient information · European Medicines Agency (EMA), HMPC